Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2005
06/23/2005CA2548600A1 Cathepsin cysteine protease inhibitors
06/23/2005CA2547863A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
06/23/2005CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
06/22/2005EP1544193A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
06/22/2005EP1543148A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
06/22/2005EP1543014A1 Preparation of metal complexes
06/22/2005EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
06/22/2005EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor
06/22/2005EP1542966A1 Aromatic liver x-receptor modulators
06/22/2005EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids
06/22/2005EP1542797A2 Catalyst systems for ethylene oligomerisation to linear alpha olefins
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005EP0973554B1 Chelating agents
06/22/2005CN1630644A Pyridine and pyrimidine derivatives
06/22/2005CN1630638A Aryl ureas as kinase inhibitors
06/22/2005CN1630637A Novel arylheteroalkylamine derivatives
06/22/2005CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1630515A Compounds active at the glucocorticoid receptor II
06/22/2005CN1630504A Sunscreen compositions as well as dihydropyridines and dihydropyranes
06/22/2005CN1629156A Pyrudyl and pyrimidylpiperazine derivatives, preparation method thereof and pharmaceutical composition containing the derivatives
06/22/2005CN1629141A Process for preparing milrinone
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207284C Synthesis process of pyridine and methyl pyridine
06/22/2005CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
06/22/2005CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908923 Compositions and methods for treating heart failure
06/21/2005US6908912 For controlling free-living microorganisms/biofilm growth
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/16/2005WO2005054200A1 Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators
06/16/2005WO2005054199A1 Tubulin inhibitors
06/16/2005WO2005054198A2 Therapeutics use of pyridinium compounds to modulate naadp activity
06/16/2005WO2005054197A1 Catalytic process for production of pyridine and picolines wherein the catalyst contains zirconium or tin
06/16/2005WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005WO2005054176A1 Peroxisome proliferator activated receptor modulators
06/16/2005WO2005053631A1 Microcapsules with uv filter activity and process for producing them
06/16/2005WO2005035473A3 Method for preparing ladderanes from pre-oriented polyenes
06/16/2005WO2005010011A3 Methods of synthesis of acyloxyalkyl compounds
06/16/2005WO2004071400A3 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
06/16/2005WO2004056750A8 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors
06/16/2005WO2004033436A8 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
06/16/2005US20050131235 Catalytic process for production of pyridine and picolines
06/16/2005US20050131232 Reacting an iridium compound or complex of iridium with pyridine or pyrimidine compounds in presence of Lewis Acid in an solvent; such as bis[(2-pyridinyl- kappa N)phenyl- kappa C]mono[2-(2-pyridinyl- kappa N)(4',6'-difluorophenyl- kappa C]iridium(III)
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131034 Moderator neurotransmitter release; central nervous ystem disorders ; using a N-methyl-5-(pyrimidyl or pyridyl)-4-penten-2-amine
06/16/2005US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
06/16/2005US20050131017 HIV protease inhibiting compounds
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/16/2005US20050130966 Sodium channel modulators
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade
06/16/2005US20050130941 Methods of treating alzheimer's disease
06/16/2005US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic;
06/16/2005DE4217248B4 Vinylverbindungen Vinyl compounds
06/16/2005CA2857067A1 Tubulin inhibitors
06/16/2005CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005CA2547791A1 Therapeutics use of pyridinium compounds to modulate naadp activity
06/16/2005CA2547212A1 Peroxisome proliferator activated receptor modulators
06/16/2005CA2545422A1 Tubulin inhibitors
06/15/2005EP1541557A1 Phenylpyridine compound and bactericidal composition containing the same
06/15/2005EP1539770A1 Preparation of metal amide complexes
06/15/2005EP1539725A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539147A1 Methods of treating microbial infections in humans and animals
06/15/2005EP1538907A2 Inhibitors of ftsz and uses thereof
06/15/2005EP1349856B1 Isoindolin-1-one glucokinase activators
06/15/2005EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/15/2005EP1305301B1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1244625B1 4-pyridinyl-n-acyl-l-phenylalanines
06/15/2005EP1222194B1 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
06/15/2005EP1134219B1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
06/15/2005EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
06/15/2005CN1628102A Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B)
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1628097A Astaxanthin esters
06/15/2005CN1628095A Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
06/15/2005CN1628088A Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
06/15/2005CN1628087A Production of alkenones
06/15/2005CN1626540A Iridium compound and organic electroluminescent device using the same
06/15/2005CN1626532A Amide compounds
06/15/2005CN1626519A Industrialized method for preparing 2-chlorine-5-fluorin-nicotinic aicd
06/15/2005CN1626518A Method for synthesizing ramification in benzamide class of pyridyl
06/15/2005CN1626517A Method of synthesized pyridyl of substituting ramification in urea class
06/15/2005CN1206231C 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 633